Ms Alexandra van Dissel
Amsterdam University Medical Centre, Amsterdam (Netherlands (The))
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Early experience with selexipag for the treatment of adults with pulmonary arterial hypertension associated with congenital heart disease
Event: ESC Congress 2020
Topic: Pharmacotherapy
Session: Congenital Heart Disease and Pediatric Cardiology ePosters
Refining the 2015 European guidelines risk assessment tool for pulmonary arterial hypertension in adult congenital heart disease
Event: ESC Congress 2019
Topic: Adult Congenital Heart Disease (ACHD)
Session: Clinical aspects in congenital heart disease
Repeated measurements of cardiac biomarkers for risk prediction in pulmonary arterial hypertension associated with congenital heart disease: a 10-year observational cohort study
Event: ESC Congress 2018
Topic: Epidemiology, Prognosis, Outcome
Session: Risk stratification in congenital heart disease
Systemic right ventricular function: temporal trends and risk for events
Event: ESC Congress 2018
Topic: Cardiac Magnetic Resonance (CMR)
Session: Congenital heart disease diagnostic aspects
A congenital anomaly underlying mitral valve disease.
Event: ESC Congress 2018
Topic: Clinical
Session: Squaring the circle: from congenital to acquired complex valvular and myocardial disease
QRS complex in adults with systemic right ventricles: signs of poor prognosis
Event: ESC Congress 2017
Topic: Grown-up congenital heart disease and surgery
Session: Novel insights in congenital heart disease
A multi-biomarker model identifies patients with PAH-CHD at highest risk for mortality
Event: ESC Congress 2017
Topic: Grown-up congenital heart disease and surgery
Session: Novel insights in congenital heart disease
Long-term clinical outcomes of a randomized controlled trial comparing valsartan to placebo in patients with systemic right ventricles
Event: ESC Congress 2017
Topic: Grown-up congenital heart disease and surgery
Session: Contemporary management of risk factors in congenital heart disease
ESC 365 is supported by
